Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TRPV1 | Q8NER1 | 11/20 | 0.33 |
| ▸ | HTR2C | P28335 | 1/20 | 0.33 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.31 |
| ▸ | KCNE1 | P15382 | 3/20 | 0.30 |
| ▸ | KCNQ1 | P51787 | 3/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7297848 | 0.88 | KCNE1 (0.35) | TRPV1HTR2CCYP3A4KCNE1KCNQ1 | |
| SCHEMBL7290029 | 0.79 | AKR1B1 (0.37) | TRPV1HTR2CCYP3A4 | |
| SCHEMBL7300510 | 0.77 | CYP2D6 (0.33) | CYP3A4 | |
| SCHEMBL7301405 | 0.71 | HTR2C (0.40) | TRPV1HTR2CCYP3A4KCNE1KCNQ1 | |
| SCHEMBL9983051 | 0.69 | ADRA2A (0.38) | TRPV1KCNE1KCNQ1 | |
| SCHEMBL7294345 | 0.69 | — | — | |
| SCHEMBL7298874 | 0.69 | KCNE1 (0.39) | CYP3A4KCNE1KCNQ1 | |
| SCHEMBL2319623 | 0.68 | MAOB (0.47) | — | |
| SCHEMBL9585171 | 0.67 | AKR1B1 (0.39) | CYP3A4 | |
| SCHEMBL3319723 | 0.67 | TRPV1 (0.42) | TRPV1HTR2CCYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5260444-A | Cardiovascular, hypotensive | WAKUNAGA SEIYAKU KABUSHIKI KAISHA (JP) | 1993-11-09 | — | — | US | disclosed |
| US-5208245-A | Hypotensive agents | WAKUNAGA SEIYAKU KABUSHIKI KAISHA (JP) | 1993-05-04 | — | — | US | disclosed |
| EP-0460418-A2 | Novel Dihydropyridine derivative | WAKUNAGA SEIYAKU KABUSHIKI KAISHA (JP) | 1991-12-11 | — | — | EP | disclosed |